Cargando…
Cannabis for Neuropathic Pain in Multiple Sclerosis—High Expectations, Poor Data
Autor principal: | Rudroff, Thorsten |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6817484/ https://www.ncbi.nlm.nih.gov/pubmed/31695613 http://dx.doi.org/10.3389/fphar.2019.01239 |
Ejemplares similares
-
Cannabis and Multiple Sclerosis—The Way Forward
por: Rudroff, Thorsten, et al.
Publicado: (2017) -
Multiple Sclerosis, Cannabis Use, and Clinical Disability: A Preliminary [(18)F]-Fluorodeoxyglucose Positron Emission Tomography Study
por: Kindred, John H., et al.
Publicado: (2018) -
CANNABIS USE AND RISK OF FALLING IN OLDER ADULTS
por: Rudroff, Thorsten
Publicado: (2022) -
Cannabidiol to Improve Mobility in People with Multiple Sclerosis
por: Rudroff, Thorsten, et al.
Publicado: (2018) -
Cannabis-Based Medicines and Medical Cannabis for Chronic Neuropathic Pain
por: Petzke, Frank, et al.
Publicado: (2021)